Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+7645.3%
5Y CAGR+1351.7%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+7645.3%/yr
vs +78.4%/yr prior
5Y CAGR
+1351.7%/yr
Recent acceleration
Acceleration
+7566.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
644790.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$8.08T+54148715.4%
2024$14.93M-36.2%
2023$23.39M+34.5%
2022$17.40M+20.2%
2021$14.48M+15.5%
2020$12.54M+56.4%
2019$8.02M+366.7%
2018$1.72M-46.1%
2017$3.19M+35.4%
2016$2.35M-